News

IHC Resourceswww.abcam.com/IHC-kits-and-reagentswww.abcam.com/IHC-primary-antibodieswww.abcam.com/IHC-secondary-antibodies Immunohistochemistry (IHC) uses antibodies to detect the location of proteins and other antigens in tissue sections. The antibody-antigen interaction is visualized using either chromogenic detection with a colored enzyme substrate, or fluorescent detection with a fluorescent dye.Although less quantitative than assays such as western blotting or ELISA, IHC gives invaluable information about protein localization in the context of intact tissue. Protein expression patterns are tremendously valuable for pathologists and as diagnostic tools. Essential to a successful IHC experiment…

How does the new coronavirus compare with the flu? By Rachael Rettner – Senior Writer Editor’s note: Updated March 6 with the latest information on COVID-19.  The new coronavirus outbreak has made headlines in recent weeks, but there’s another viral epidemic hitting countries around the world: flu season. But how do these viruses compare, and which one is really more worrisome? So far, the new coronavirus has led to more than 100,000 illnesses and more than 3,000 deaths worldwide. But…

The European Society of Pathology Quality Assurance (ESPQA) Foundation and KU Leuven EQA scheme coordination centre are happy to invite you to participate in the ESP Lung External Quality Assessment Scheme 2020. The program aims to ensure optimal accuracy and proficiency in biomarker testing in non-small cell lung cancer. All countries can participate in the scheme. Registrations for the different subschemes are now open. Please note that the registration deadline is February 14, 2020 Set up of the scheme:  …

The European Society of Pathology (ESP) is delighted to announce the Second European Society of Pathology Academy (ESPA), scheduled to take place from 20-23 June 2020 in Waterloo, Belgium. The ESP Academy Is an intensive, interactive four-day workshop designed to support early career pathologists advances research excellence and innovation among young pathologists and scientists in the field of human pathology provides solutions for building up a research strategy and academic career to become a leader in pathology identifies the best…

The European Society of Pathology Quality Assurance (ESPQA) is pleased to announce that registration for the Colorectal Carcinoma (CRC) EQA Scheme (KRAS/NRAS/BRAF mutations) is now open. This programme aims to ensure optimal accuracy and proficiency in biomarker testing in colorectal cancer in all countries. For your information the EQA Plan 2020 containing also Colorectal Carcinoma (CRC) scheme (KRAS/NRAS/BRAF mutations) that is running under the scientific supervision of the European Society of Pathology (www.esp-pathology.org) is available and you can order this…